Elevance Health Inc. (ELV) quarterly income statement — complete revenue, gross profit & net income history
| Revenue | 50.18B | 49.75B | 50.71B | 49.78B | 48.89B | 45.44B | 45.15B | 43.65B | 42.58B | 42.65B | 42.85B | 43.67B |
| Revenue Growth % | 2.64% | 9.47% | 12.33% | 14.04% | 14.83% | 6.55% | 5.36% | -0.06% | 0.96% | 6.81% | 7.29% | 13.05% |
| Medical Costs & Claims | 41.08B | 38.06B | 38.14B | 36.71B | 35.31B | 33.5B | 32.95B | 30.57B | 30.55B | 31.33B | 30.61B | 31.6B |
| Medical Cost Ratio % | 81.86% | 76.52% | 75.21% | 73.74% | 72.23% | 73.72% | 72.98% | 70.05% | 71.74% | 73.47% | 71.43% | 72.37% |
| Gross Profit | 9.1B | 11.68B | 12.57B | 13.07B | 13.58B | 11.94B | 12.2B | 13.07B | 12.03B | 11.31B | 12.24B | 12.07B |
| Gross Margin % | 18.14% | 23.48% | 24.79% | 26.26% | 27.77% | 26.28% | 27.02% | 29.95% | 28.26% | 26.53% | 28.57% | 27.63% |
| Gross Profit Growth % | -32.96% | -2.18% | 3.07% | -0.03% | 12.87% | 5.56% | -0.38% | 8.34% | 5.66% | 16.22% | 16.4% | 22.68% |
| Operating Expenses | 6.44B | 11.1B | 10.81B | 10.44B | 10.44B | 11B | 10.48B | 10.05B | 8.83B | 10.05B | 10.33B | 9.37B |
| OpEx / Revenue % | 12.84% | 22.31% | 21.32% | 20.97% | 21.35% | 24.2% | 23.22% | 23.02% | 20.73% | 23.57% | 24.11% | 21.45% |
| Depreciation & Amortization | 112M | 406M | 387M | 380M | 373M | 398M | 329M | 335M | 331M | 424M | 426M | 433M |
| Combined Ratio % | 94.7% | 98.83% | 96.54% | 94.71% | 93.58% | 97.92% | 96.21% | 93.07% | 92.47% | 97.05% | 95.54% | 93.81% |
| Operating Income | 2.66B | 581M | 1.76B | 2.63B | 3.14B | 946M | 1.71B | 3.03B | 3.2B | 1.26B | 1.91B | 2.7B |
| Operating Margin % | 5.3% | 1.17% | 3.46% | 5.29% | 6.42% | 2.08% | 3.79% | 6.93% | 7.53% | 2.95% | 4.46% | 6.19% |
| Operating Income Growth % | -15.28% | -38.58% | 2.63% | -12.99% | -1.97% | -24.92% | -10.51% | 11.99% | 11.64% | -1.1% | -18.25% | 15.97% |
| EBITDA | 2.77B | 987M | 2.14B | 3.01B | 3.51B | 1.34B | 2.04B | 3.36B | 3.54B | 1.68B | 2.34B | 3.13B |
| EBITDA Margin % | 5.53% | 1.98% | 4.23% | 6.05% | 7.19% | 2.96% | 4.52% | 7.7% | 8.3% | 3.95% | 5.46% | 7.18% |
| Interest Expense | 357M | 366M | 351M | 341M | 344M | 340M | 300M | 280M | 265M | 259M | 259M | 261M |
| Non-Operating Income | 0 | 0 | 0 | 0 | 0 | 0 | 39M | -240M | 0 | 0 | 0 | 0 |
| Pretax Income | 2.3B | 215M | 1.41B | 2.29B | 2.8B | 606M | 1.37B | 2.99B | 2.94B | 1B | 1.65B | 2.44B |
| Pretax Margin % | 4.59% | 0.43% | 2.77% | 4.6% | 5.72% | 1.33% | 3.04% | 6.84% | 6.9% | 2.35% | 3.86% | 5.59% |
| Income Tax | 544M | -331M | 219M | 548M | 613M | 193M | 365M | 685M | 690M | 170M | 354M | 585M |
| Effective Tax Rate % | 23.61% | -153.95% | 15.58% | 23.91% | 21.92% | 31.85% | 26.58% | 22.94% | 23.48% | 16.98% | 21.4% | 23.97% |
| Net Income | 1.76B | 547M | 1.19B | 1.74B | 2.18B | 418M | 1.02B | 2.3B | 2.25B | 856M | 1.29B | 1.85B |
| Net Margin % | 3.52% | 1.1% | 2.34% | 3.5% | 4.47% | 0.92% | 2.25% | 5.27% | 5.28% | 2.01% | 3.01% | 4.24% |
| Net Income Growth % | -19.19% | 30.86% | 17.03% | -24.22% | -2.8% | -51.17% | -21.18% | 24.12% | 12.92% | -1.04% | -19.59% | 13.19% |
| EPS (Diluted) | 8.00 | 2.47 | 5.32 | 7.72 | 9.61 | 1.81 | 4.36 | 9.85 | 9.59 | 3.63 | 5.45 | 7.79 |
| EPS Growth % | -16.75% | 36.46% | 22.02% | -21.62% | 0.21% | -50.14% | -20% | 26.44% | 15.54% | 1.11% | -17.67% | 15.75% |
| EPS (Basic) | 8.00 | 2.47 | 5.32 | 7.72 | 9.64 | 1.84 | 4.36 | 9.91 | 9.65 | 3.67 | 5.48 | 7.83 |
| Diluted Shares Outstanding | 220.4M | 221.8M | 225.8M | 225.8M | 227.2M | 231.1M | 233.1M | 233.4M | 234.2M | 235.8M | 236.5M | 237.8M |